Cargando…
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
Autores principales: | Michaelis, Katherine A., Norgard, Mason A., Zhu, Xinxia, Levasseur, Peter R., Sivagnanam, Shamilene, Liudahl, Shannon M., Burfeind, Kevin G., Olson, Brennan, Pelz, Katherine R., Ramos, Diana M. Angeles, Maurer, H. Carlo, Olive, Kenneth P., Coussens, Lisa M., Morgan, Terry K., Marks, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858433/ https://www.ncbi.nlm.nih.gov/pubmed/31729370 http://dx.doi.org/10.1038/s41467-019-13151-z |
Ejemplares similares
-
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
por: Michaelis, Katherine A., et al.
Publicado: (2019) -
Microglia in the hypothalamus respond to tumor‐derived factors and are protective against cachexia during pancreatic cancer
por: Burfeind, Kevin G., et al.
Publicado: (2020) -
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
por: Olson, Brennan, et al.
Publicado: (2021) -
MyD88 signalling is critical in the development of pancreatic cancer cachexia
por: Zhu, Xinxia, et al.
Publicado: (2019) -
Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers
por: Mi, Haoyang, et al.
Publicado: (2022)